Prime Medicine, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PRME, updated each market day.
PRME AI Sentiment
AI predicts Prime Medicine, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Prime Medicine, Inc. Common Stock
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Sector
Exchange
Market Cap
$633,738,148
Cap Tier
Employees
146
Headquarters
CAMBRIDGE, MA
Listed Since
Oct. 20, 2022
Website
PRME Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PRME Volatility
Prime Medicine, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
